Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial-Reference-Cited by-同舟云学术

Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial

Published:1998-07 Issue:9121 Volume:352 Page:17-20
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Endocrine treatment of hepatocellular carcinoma: any evidence of benefit?;Pignata;Eur J Cancer,1998

2. Induction of hepatic tumors by diethylstilbestrol alone or in synergism with N-nitrosobutylurea in castrated male WF rats;Sumi;J Natl Cancer Inst,1983

3. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats;Yager;Cancer Res,1980

4. P-analysis of DNA adducts in rats during ethynylestradiol induced hepatocarcinogenesis and effect of tamoxifen on DNA adduct formation;Shinomura;Jpn J Cancer Res,1992

5. The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro;Francavilla;Hepatology,1989

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tamoxifen for adults with hepatocellular carcinoma;Cochrane Database of Systematic Reviews;2024-08-12

2. Direct‐acting antivirals in women of reproductive age infected with hepatitis C virus;Journal of Viral Hepatitis;2024-03-14

3. The Role of Sex in Acute and Chronic Liver Damage;International Journal of Molecular Sciences;2022-09-13

4. Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen Signaling Pathway;Frontiers in Oncology;2022-01-12

5. Hepatocellular Carcinoma;Sex/Gender-Specific Medicine in the Gastrointestinal Diseases;2022